Chemotherapy-induced Peripheral Neuropathy (CIPN) Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled Phase 1b/2a Study to Evaluate the Safety, Tolerability, and Efficacy of Repeated Subcutaneous Administration of SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN) After the End of Chemotherapeutic Treatment
The study will be conducted in adult patients with Chemotherapy-induced Peripheral Neuropathy (CIPN) that has been persistent for at least 3 months following completion of chemotherapy. A total of 60 patients will be enrolled in equal numbers of a placebo group and two different SON-080 dose groups. Treatment period will be 12 weeks long and patients will be followed-up for an additional 12 weeks.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03299582 -
PREventing CHemotherapy Induced Neuropathy (PreChIN)
|
N/A | |
| Completed |
NCT02129686 -
A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT04739631 -
Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
| Recruiting |
NCT05855044 -
Efficacy of External Application of Rosemary Oil in Patients With Chemotherapy-Induced Peripheral Neuropathy: a Feasibility Study
|
N/A | |
| Not yet recruiting |
NCT04651907 -
Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN)
|
N/A | |
| Terminated |
NCT03634527 -
Auricular Point Acupressure: Examining the Scientific Underpinnings of Pain Relief
|
N/A | |
| Recruiting |
NCT03248193 -
Concomitant Limb Cryocompression and Scalp Cooling to Reduce Paclitaxel-induced Neuropathy and Alopecia
|
N/A |